Skip to main content
Atrás
LBRX logo

LB Pharmaceuticals Inc Common Stock

Calidad de datos: 100%
LBRX
NASDAQ Healthcare Biotechnology
$23.67
▲ $0.14 (0.60%)
Cap. Mercado: 598.83M
Rango del Día
$23.48 $24.47
Rango de 52 Semanas
$13.36 $27.55
Volumen
113,426
Promedio 50D / 200D
$23.15 / $19.54
Cierre Anterior
$23.53

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E -9.5 0.4
P/B 2.9
ROE % 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.2

Puntos Clave

Negative free cash flow of -53.82M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio3.56
Interest Coverage0.00

Valoración

P/E Ratio
-9.49
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -63.10M
ROE N/A ROA -188.17%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -53.82M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.56
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -9.49 P/B Ratio N/A
P/S Ratio N/A PEG Ratio 0.00
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 598.83M Enterprise Value 579.55M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 0.0 0.0 0.0
Net Income -63.10M -6.28M -14.35M
EPS (Diluted) -17.83 -1.77 -4.05
Gross Profit 0.0 0.0 0.0
Operating Income -64.83M -11.38M -2.81M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 33.53M 45.66M 21.49M
Total Liabilities 128.09M 80.13M 50.30M
Shareholders' Equity -94.55M -34.47M -28.81M
Total Debt 3.70M 0.0 24.15M
Cash & Equivalents 22.98M 14.98M 21.40M
Current Assets 28.88M 45.63M 21.49M
Current Liabilities 8.11M 2.61M 469,000.0